Digital Pathology Blog: Visiopharm Introduces HER2-CONNECT™: Changing HER2 IHC Analysis in Important Ways

Links shared publicly online about this topic.

706
total visits

Digital Pathology Blog: Visiopharm Introduces HER2-CONNECT™: Changing HER2 IHC Analysis in Important Ways

Visiopharm A/S is introducing a novel and patent protected method for determining the HER2 status in tissue sections. This method represents a significant technological breakthrough that effectively addresses several of the practical issues encountered in digital pathology when working with...

View full resource at tissuepathology.typepad.com

Tags: Disease and Condition, Pathology

Most Recently Shared on November 23, 2010 at 1:00 pm By:

tissuepathology

Visiopharm Introduces HER2-CONNECTâ„¢: Changing HER2 IHC Analysis in Important Ways http://bit.ly/h5x8LA

2 years ago...

Retweet

Favorite

Digital Pathology Blog: Visiopharm’s New APPCenter Rapidly Expands Their APP Library and Introduces a Customer Contributor Program

tissuepathology.com — “Visiopharm’s rapidly expands the APPCenter and showcases over 30 APPs for cancer research, diabetes, neuroscience, respiratory, and much more. APPs are created and validated in collaboration between experts in the field and Visiopharm application scientists and programmers. Experts benefit from...” View full resource at tissuepathology.com

Most Recently Shared on March 17, 2012 at 1:07 pm By:

tissuepathology Physician, Doctor, and Pathologist

Visiopharm’s New APPCenter Rapidly Expands Their APP Library and Introduces a Customer Contributor Program http://t.co/KPGA4238

2 months ago...

Retweet

Favorite